✦ LIBER ✦

NCIC CTG IND 98: a phase I dose escalation study of raltitrexed (Tomudex) Plus doxorubicin (DOX) in patients with advanced cancer

✍ Scribed by Bjarnason, G.; Charpentier, D.; Wong, R.; Goel, R.; Smith, M.; Abugaber, A.; Matthews, S.; Seymour, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of Tomudex and Doxorubicin

✍ Georg A. Bjarnason; Danielle Charpentier; Ralph Wong; Rakesh Goel; Lynn Douglas; 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 62 KB

NCIC CTG IND 113: two phase I dose escal

✍ Hirte, H.; Stewart, D.; Goel, R.; Chouinard, E.; Huan, S.; Elias, I.; Matthews, 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Phase I/II Dose-Escalation Study of Peme

✍ Howard Hochster; Erika Kettner; Hendrik Kröning; Klaus Becker; Florian Lordick; 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 111 KB

Phase I dose escalation and pharmacokine

✍ Danson, S; Ferry, D; Alakhov, V; Margison, J; Kerr, D; Jowle, D; Brampton, M; Ha 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

A National Cancer Institute of Canada Cl

✍ J.A. Maroun; D. Jonker; L. Seymour; R. Goel; M. Vincent; W. Kocha; C. Cripps; B. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 131 KB

A phase I study of T900607 given once ev

✍ K.A. Gelmon; K. Belanger; C. Britton; D. Soulières; S. Janke; J. Dionne; J. Powe 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 165 KB